Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
156.20    3.40 (2.23%)
Bid:
156.00
Ask:
156.40
Spread: 0.40 (0.256%)
Market Cap: £893.96m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Pre-close trading update

17 Dec 2015 07:00

ELEMENTIS PLC - Pre-close trading update

ELEMENTIS PLC - Pre-close trading update

PR Newswire

London, December 16

17 December 2015

Elementis plc – pre-close trading updateElementis plc (ELM.L, the "Company" or the "Group"), the Global Specialty Chemicals Company, today issues a trading update ahead of its results for the full year ending 31 December 2015, which will be announced on 1 March 2016.Since we issued our Interim Management Statement on 30 October 2015, markets have continued to be challenging and earnings per share for the current year is now projected to be at the lower end of the range of market expectations. Due to the cash generative nature of the Group and our ongoing focus on cash management, it is still anticipated that the Group’s year end net cash balance will be higher than the prior year balance of $64.2 million.Looking towards 2016, management expects Specialty Products to make progress against the current year, based on its strong and diverse market positions, new product launches and resilient contribution margins.In Chromium, the business will continue to benefit from its North American business model, where our unique delivery systems provide a value added service to customers. Export sales from North America, however, are likely to remain under pressure due to the strong US dollar. In addition, operating profit in the current year has benefited from approximately $5 million of “one-time” items, relating to a legal settlement and property easements which will not be repeated in 2016. Consequently, operating profit in 2016 in our Chromium operations is expected to be lower than the current year.Strong cash flow generation will continue to be an important feature of the Group’s performance in 2016 and both businesses will benefit next year from the recently announced measured actions to reduce our cost base.ENDSEnquiries:

Elementis+ 44 (0) 207 067 2999
David Dutro, Chief ExecutiveBrian Taylorson, Finance Director
FTI Consulting
+ 44 (0) 203 727 1000
Deborah Scott
Matthew Cole
Date   Source Headline
8th Jun 20265:14 pmRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSCommencement of share buyback programme
2nd Jun 20267:00 amRNSSale of Pharma business & intended buyback launch
1st Jun 20269:58 amRNSTotal Voting Rights
5th May 20265:26 pmRNSHolding(s) in Company
1st May 20269:59 amRNSTotal Voting Rights
29th Apr 20263:47 pmRNSResult of AGM
29th Apr 20267:00 amRNSFirst quarter trading update
8th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20263:06 pmRNSDirector/PDMR Shareholding
1st Apr 202610:18 amRNSTotal Voting Rights
30th Mar 20265:06 pmRNSCorrection - Admission to Trading
30th Mar 20261:58 pmRNSAdmission to Trading
26th Mar 202612:09 pmRNSNotice of AGM and Annual Report & Accounts
19th Mar 20267:00 amRNSDirectorate change
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:39 pmRNSDirector/PDMR Shareholding
9th Mar 20265:14 pmRNSHolding(s) in Company
5th Mar 20265:11 pmRNSBlocklisting Interim Review
5th Mar 20264:57 pmRNSPreliminary Results - Correction
5th Mar 20267:00 amRNSPreliminary Results
2nd Mar 202610:00 amRNSTotal Voting Rights
25th Feb 20264:22 pmRNSDirectorate change
2nd Feb 202610:05 amRNSTotal Voting Rights
21st Jan 20267:00 amRNSTrading Update
2nd Jan 202611:10 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSConfirmation of Board changes
2nd Jan 20267:00 amRNSConfirmation of Board changes
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
15th Dec 20257:00 amRNSCompletion of Buyback programme
15th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20255:35 pmRNSTransaction in Own Shares
10th Dec 20256:12 pmRNSTransaction in Own Shares
9th Dec 20255:55 pmRNSTransaction in Own Shares
8th Dec 20255:52 pmRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20256:06 pmRNSTransaction in Own Shares
3rd Dec 20255:28 pmRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:49 pmRNSTransaction in Own Shares
28th Nov 20255:49 pmRNSTransaction in Own Shares
27th Nov 20255:40 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSElementis acquires personal care specialist
25th Nov 20255:44 pmRNSTransaction in Own Shares
24th Nov 20256:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.